Navigation Links
Mindray Medical to Present at the Credit Lyonnais Securities Asia Investors' Forum
Date:8/27/2009

SHENZHEN, China, Aug. 27 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that the Company will present at the Credit Lyonnais Securities Asia (CLSA) Investors' Forum, which will be held at the Grand Hyatt Hotel in Hong Kong on September 21-25, 2009.

Ms. May Li, Mindray's director of investor relations, and Ms. Winnie Liang, Mindray's manager of investor relations, will attend the forum and present a corporate overview on behalf of Mindray on September 22, 2009 from 2:00-3:00 P.M. HKT.

To learn more about the CLSA Investors' Forum, please visit https://www.clsa.com/corporate-access/investor-forums.php .

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

    For investor and media inquiries please contact:

    In the U.S.:

     Evan Smith, CFA
     FD
     Tel:   +1-212-850-5606
     Email: evan.smith@fd.com

     John Capodanno
     FD
     Tel:   +1-212-850-5705
     Email: john.capodanno@fd.com

    In China:

     Cathy Gao
     Tel:   +86-755-2658-2518
     Email: cathy.gao@mindray.com

'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference
2. Mindray Announces Second Quarter 2009 Financial Results
3. Mindray Medical Provides Mid-Year Update on Product Development and GPO Contracts
4. Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009
5. Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
6. Mindray Announces First Quarter 2009 Financial Results
7. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
8. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
9. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
10. Mindray Announces Option Exchange Offer
11. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
Breaking Medicine Technology: